Tags

Type your tag names separated by a space and hit enter

Embryonic Regulation and Research: What Is the Status of Human Germline Genome Editing in Australia?
J Law Med. 2020 Apr; 27(3):718-740.JL

Abstract

This article considers the status of human germline genome editing in Australia. Through an analysis of the current State, Territory and Commonwealth legal and ethical regulatory frameworks, and incorporating the capability approach to health justice proposed by Martha Nussbaum and Amartya Sen, the article argues that heritable alterations using CRISPR/Cas9 technology in a clinical context are inevitable in Australia, so the law needs to respond adequately to these scientific advances. The article concludes that human germline genome editing is currently not, and should not, be lawful in Australia, except for research purposes.

Authors+Show Affiliations

LLB (Hons) Student, Griffith Law School, Griffith University, BHSc, Griffith University.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32406632

Citation

Burbery, Rose. "Embryonic Regulation and Research: what Is the Status of Human Germline Genome Editing in Australia?" Journal of Law and Medicine, vol. 27, no. 3, 2020, pp. 718-740.
Burbery R. Embryonic Regulation and Research: What Is the Status of Human Germline Genome Editing in Australia? J Law Med. 2020;27(3):718-740.
Burbery, R. (2020). Embryonic Regulation and Research: What Is the Status of Human Germline Genome Editing in Australia? Journal of Law and Medicine, 27(3), 718-740.
Burbery R. Embryonic Regulation and Research: what Is the Status of Human Germline Genome Editing in Australia. J Law Med. 2020;27(3):718-740. PubMed PMID: 32406632.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Embryonic Regulation and Research: What Is the Status of Human Germline Genome Editing in Australia? A1 - Burbery,Rose, PY - 2020/5/15/entrez PY - 2020/5/15/pubmed PY - 2020/5/15/medline KW - CRISPR/Cas9 KW - capability approach KW - ethical regulation KW - gene editing KW - genome editing KW - germline KW - human embryo KW - statutory interpretation SP - 718 EP - 740 JF - Journal of law and medicine JO - J Law Med VL - 27 IS - 3 N2 - This article considers the status of human germline genome editing in Australia. Through an analysis of the current State, Territory and Commonwealth legal and ethical regulatory frameworks, and incorporating the capability approach to health justice proposed by Martha Nussbaum and Amartya Sen, the article argues that heritable alterations using CRISPR/Cas9 technology in a clinical context are inevitable in Australia, so the law needs to respond adequately to these scientific advances. The article concludes that human germline genome editing is currently not, and should not, be lawful in Australia, except for research purposes. SN - 1320-159X UR - https://www.unboundmedicine.com/medline/citation/32406632/Embryonic_Regulation_and_Research:_What_Is_the_Status_of_Human_Germline_Genome_Editing_in_Australia DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.